NuCana

NCNANasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.494 M

$1.32 -1.49%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

20,809,854,947

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#460Addex TherapeuticsADXN$6.01M
#461Xtl BiopharmaceuticalsXTLB$5.84M
#462NuCanaNCNA$5.49M
#463Processa PharmaceuticalsPCSA$5.14M
#464Lakewood-Amedex BiotherapeuticsLABT$4.86M

What if NuCana were worth as much as…

Open the what-if tool →

Gold $30.3T

$7,273,970

Per share 5,510,583× higher

Bitcoin $1.72T

$413,218.55

Per share 313,044× higher

Nvidia $5.48T

$1,316,650

Per share 997,462× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for NuCana are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.